(PLOS) The public announcement last fall from China regarding gene editing on human embryos, conducted without the benefit of scientific review or ethical debate, has raised global concerns that more rigorous standards must be established to guide research in germline gene therapy, according to a new article publishing on April 30 in the open-access journal PLOS Biology by medical ethicist Arthur L. Caplan of the Division of Medical Ethics at NYU School of Medicine.
from EurekAlert! - Technology, Engineering and Computer Science http://bit.ly/2J7eDzW
Wednesday, May 1, 2019
What can be done to prevent another CRISPR crisis?
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment